Home » Newsletters » BioWorld

BioWorld

April 4, 1997

View Archived Issues

Scios' Lead Product Fails In Phase III; Stock Dives 30 Percent

Apollo BioPharmaceutics Fails To Close Initial Public Offering

Breakthrough May Help In Development Of Pain-Killers

FDA Forges Ahead On Harmonization Efforts;Issues Draft Guidelines On Genotoxicit

Other News to Note